The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab (Q57279309)

Wing Chan

0 references

Dennis D Weisenburger

Dennis D. Weisenburger

0 references

Julie M Vose

Julie Vose

0 references

Andreas Rosenwald

Andreas Rosenwald

0 references

Rita M. Braziel

Rita Braziel

0 references

Timothy Greiner

Timothy Greiner

0 references

author name string

Paul N. Meyer

0 references

Kai Fu

0 references

Lynette Smith

0 references

German Ott

0 references

Georg Lenz

0 references

Louis Staudt

American Journal of Clinical Pathology

0 references

language of work or name

English

1 reference

inferred from

publication date

January 2011

0 references

published in

American Journal of Clinical Pathology

0 references

volume

135

0 references

issue

0 references

page(s)

54-61

0 references

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Stromal gene signatures in large-B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

General morphological and biological features of neoplasms: integration of molecular findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Distribution of the CD68 macrophage/myeloid associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

SPARC: a matricellular regulator of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Rituximab therapy in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY

Gene expression profiling of pediatric acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPJX4BJV9NLQHY